RS4204A - Dosage regimen and pharmaceutical composition for emergency contraception - Google Patents
Dosage regimen and pharmaceutical composition for emergency contraceptionInfo
- Publication number
- RS4204A RS4204A YUP-42/04A YUP4204A RS4204A RS 4204 A RS4204 A RS 4204A YU P4204 A YUP4204 A YU P4204A RS 4204 A RS4204 A RS 4204A
- Authority
- RS
- Serbia
- Prior art keywords
- emergency contraception
- pharmaceutical compositions
- dosage regimen
- levonorgestrel
- active ingredient
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- WWYNJERNGUHSAO-XUDSTZEESA-N (+)-Norgestrel Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 WWYNJERNGUHSAO-XUDSTZEESA-N 0.000 abstract 3
- 239000004480 active ingredient Substances 0.000 abstract 3
- 229960004400 levonorgestrel Drugs 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Pronalazak se odnosi na režim doziranja za urgentnu zaštitu, na farmaceutske formulacije koje se koriste u istu tu svrhu, na upotrebu levonorgestrela za proizvodnju farmaceutskih formulacija koje se koriste u istu tu svrhu, kao i na proces proizvodnje ovih farmaceutskih formulacija. Prema pronalasku urgentna zaštita se ostvaruje upotrebom levonorgestrela kao aktivne komponente do 72 časa posle koitusa. Farmaceutska formulacija za urgentnu zaštitu prema datom pronalasku je okarakterisana time što je u svakoj dozi za primenu, sadržaj levonorgestrela kao aktivne supstance samo 1.5+0.2 mg u smeši sa poznatim ekscipientima, rastvaračima za razblaživanje, veštačkim pojačivačima ukusa i arome, stabilizatorima, kao i sa aditivima koji se nalaze u formulaciji ili potpomažu formulaciju, a koji se uobičajeno koriste u farmaceutskoj praksi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0105173A HU227198B1 (en) | 2001-11-27 | 2001-11-27 | Pharmaceutical composition for emergency contraception containing levonorgestrel |
PCT/HU2002/000129 WO2003045397A1 (en) | 2001-11-27 | 2002-11-26 | Dosage regimen and pharmaceutical composition for emergency contraception |
Publications (2)
Publication Number | Publication Date |
---|---|
RS4204A true RS4204A (en) | 2007-02-05 |
RS50768B RS50768B (sr) | 2010-08-31 |
Family
ID=89998939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-42/04A RS50768B (sr) | 2001-11-27 | 2002-11-26 | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu |
Country Status (33)
Country | Link |
---|---|
US (1) | US20050288264A2 (sr) |
EP (1) | EP1448207B1 (sr) |
JP (1) | JP2005516904A (sr) |
KR (1) | KR100908161B1 (sr) |
CN (1) | CN1551774A (sr) |
AP (1) | AP1849A (sr) |
AT (1) | ATE293978T1 (sr) |
AU (1) | AU2002347401A1 (sr) |
BR (1) | BR0210595A (sr) |
CA (1) | CA2450359C (sr) |
DE (1) | DE60203929T2 (sr) |
DK (1) | DK1448207T3 (sr) |
EA (1) | EA006545B1 (sr) |
EC (1) | ECSP045171A (sr) |
ES (1) | ES2239727T3 (sr) |
GE (1) | GEP20063882B (sr) |
HR (1) | HRP20040584B1 (sr) |
HU (1) | HU227198B1 (sr) |
IL (1) | IL159394A0 (sr) |
IS (1) | IS2691B (sr) |
MA (1) | MA27076A1 (sr) |
MX (1) | MXPA04005104A (sr) |
NO (1) | NO333984B1 (sr) |
NZ (1) | NZ530056A (sr) |
OA (1) | OA12730A (sr) |
PL (1) | PL206010B1 (sr) |
PT (1) | PT1448207E (sr) |
RS (1) | RS50768B (sr) |
SI (1) | SI1448207T1 (sr) |
TN (1) | TNSN04048A1 (sr) |
UA (1) | UA79942C2 (sr) |
WO (1) | WO2003045397A1 (sr) |
ZA (1) | ZA200404114B (sr) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2009006823A (es) * | 2006-12-20 | 2009-07-03 | Duramed Pharmaceuticals Inc | Formas de dosificacion solidas de desintegracion oral que comprenden progestina y metodos para hacer y usar las mismas. |
US20090170823A1 (en) * | 2007-12-20 | 2009-07-02 | Duramed Pharmaceuticals, Inc. | Dosage Regimens and Pharmaceutical Compositions and Packages for Emergency Contraception |
US8512745B2 (en) | 2008-12-08 | 2013-08-20 | Laboratoire Hra Pharma | Ulipristal acetate tablets |
US9180131B2 (en) | 2008-12-12 | 2015-11-10 | Laboratoire Hra Pharma | Method for contraception |
PL2419108T3 (pl) | 2009-04-14 | 2017-08-31 | Laboratoire Hra Pharma | Sposób antykoncepcji na żądanie |
SG177284A1 (en) * | 2009-06-23 | 2012-02-28 | Bayer Pharma AG | Pharmaceutical composition for emergency contraception |
CN101732324B (zh) * | 2009-12-31 | 2011-12-07 | 广州朗圣药业有限公司 | 一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法 |
EP2714710B1 (en) | 2011-06-01 | 2016-04-06 | Estetra S.P.R.L. | Process for the production of estetrol intermediates |
ES2600703T3 (es) | 2011-06-01 | 2017-02-10 | Estetra S.P.R.L. | Proceso para la producción de intermediarios de estetrol |
EP2383279A1 (en) | 2011-07-19 | 2011-11-02 | Pantarhei Bioscience B.V. | Process for the preparation of estetrol |
US9579329B2 (en) * | 2011-08-11 | 2017-02-28 | Estetra S.P.R.L. | Use of estetrol as emergency contraceptive |
KR20150085512A (ko) | 2012-11-22 | 2015-07-23 | 바이엘 파마 악티엔게젤샤프트 | 필요시 피임을 위한 레보노르게스트렐 및 cox 억제제 함유 제약 조성물의 용도 및 적용 요법 |
BR112015029214A2 (pt) | 2013-05-23 | 2017-07-25 | Bayer Pharma AG | composição farmacêutica, seu uso e regime de aplicação dessa composição farmacêutica para contracepção conforme a necessidade |
CN103877058A (zh) * | 2014-03-26 | 2014-06-25 | 邵娜 | 一种左炔诺孕酮片及其制备工艺 |
ES2877186T3 (es) | 2015-06-18 | 2021-11-16 | Estetra Sprl | Comprimido orodispersable que contiene estetrol |
TN2017000499A1 (en) | 2015-06-18 | 2019-04-12 | Mithra Pharmaceuticals S A | Orodispersible dosage unit containing an estetrol component |
LT3310346T (lt) | 2015-06-18 | 2021-06-10 | Estetra Sprl | Burnoje disperguojama tabletė, turinti estetrolio |
GEP20217243B (en) | 2015-06-18 | 2021-04-26 | Sprl Estetra | Orodispersible dosage unit containing an estetrol component |
KR20220144885A (ko) | 2016-08-05 | 2022-10-27 | 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 | 월경통 및 생리통의 관리방법 |
TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
JOP20200260A1 (ar) | 2018-04-19 | 2019-10-19 | Estetra Sprl | مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث |
CN110917154A (zh) * | 2019-12-12 | 2020-03-27 | 上海信谊天平药业有限公司 | 一种左炔诺孕酮片的制备方法 |
US20230338355A1 (en) * | 2020-07-30 | 2023-10-26 | Acer Therapeutics Inc. | Nk antagonists for contraception |
-
2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
-
2002
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CA CA2450359A patent/CA2450359C/en not_active Expired - Lifetime
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/en active IP Right Grant
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/en not_active Expired - Lifetime
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko active IP Right Grant
-
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
-
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-24 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP1849A (en) | Dosage regimen and pharmaceutical composition for emergency contraception | |
JP2005516904A5 (sr) | ||
WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
MY129281A (en) | Use of a composition comprising formoterol and budesonide for the prevention or treatment of a acute condition of asthma | |
GEP20033131B (en) | Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity | |
BG105173A (en) | Novel salt form of pantoprazole | |
EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
SE9901573D0 (sv) | New compounds | |
EA200400007A1 (ru) | ФАРМАЦЕВТИЧЕСКИЙ СОСТАВ ДЛЯ ЭФФЕКТИВНОГО ВВЕДЕНИЯ АПОМОРФИНА, 6aR-(-)-N-ПРОПИЛ-НОРАПОМОРФИНА, ИХ ПРОИЗВОДНЫХ И ИХ ПРОЛЕКАРСТВ | |
WO2002088100A3 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
RU2003100507A (ru) | Фармацевтические композиции | |
HUP0101622A2 (hu) | Abacavir, lamivudin és zidovudin tartalmú homogén gyógyászati készítmények | |
MXPA05005781A (es) | Combinacion de ibuprofeno y oxicodona para alivio de dolor agudo. | |
AR046226A1 (es) | Formulaciones farmaceuticas que contienen saborizante con caracteristicas farmaceuticas mejoradas | |
BE2016C017I2 (sr) | ||
SE9901572D0 (sv) | New compounds | |
BR0207297A (pt) | Composição farmacêutica em forma sólida e método de preparar uma forma de dosagem sólida de um ingrediente farmaceuticamente ativo | |
CA2361081A1 (en) | Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis | |
US3197370A (en) | Pyrilamine tannate compositions | |
MXPA02006034A (es) | Formas de dosis mucosaloral de apomorfina. | |
TW200640468A (en) | Pharmaceutical product for oral contraception | |
KR920700626A (ko) | 톡소플라스마병의 치료용 약제 | |
US3567828A (en) | Organic compounds | |
US4156003A (en) | Treatment of hypertension with combination of clofibrinic acid or clofibrate with cinnarizine |